Effects of Standardized Meals on the Metabolic, Hormonal and Inflammatory Responses in Human
1 other identifier
interventional
68
1 country
1
Brief Summary
Meal composition is important for blood sugar levels in patients with diabetes. The aim of this study is to investigate if a meal composition of fat, protein and carbohydrate is important for the hormonal and inflammatory responses Patients with type 1 and type 2 diabetes and healthy controls will be included in the study. At four different occasions the participants will receive lunch with the same amount of calories but different composition of fat, protein, carbohydrate and fiber. Blood samples will be taken before and after the meals. The participants will estimate their satiety. In addition participant will fill in questionnaires about their food habits and wellbeing. This study is the first study to compare both hormonal and inflammatory responses, as well as psychological aspect of the meals, after meals with different composition. Results from this study will help to make recommendation about meal composition which is beneficial for patients with diabetes type 1 and type 2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus
Started Nov 2009
Longer than P75 for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 26, 2015
CompletedFirst Posted
Study publicly available on registry
September 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedMarch 6, 2019
March 1, 2019
6.3 years
August 26, 2015
March 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximum plasma concentration [Cmax] of glucose and triglycerides
The maximum plasma concentration of glucose and triglyceres after the meals
1 year
Secondary Outcomes (5)
Maximum plasma concentration [Cmax] of IGFBP-1
2 year
Maximum plasma concentration [Cmax] of marker of oxidative stress
2 year
Maximum plasma concentration [Cmax] of inflammatory markers
2 year
Maximum plasma concentration [Cmax] of appetite regulatory hormones
2 years
Maximum plasma concentration [Cmax] of glucagon
2 years
Study Arms (4)
High-Carb Meal
EXPERIMENTALThe 3 Groups (Control, T1DM, T2DM) will receive 4 meals with different compositions at 4 occasions (High-Carb, High-Fat, High-Protein, High-Fibr) .
High-Protein Meal
EXPERIMENTALThe 3 Groups (Control, T1DM, T2DM) will receive 4 meals with different compositions at 4 occasions (High-Carb, High-Fat, High-Protein, High-Fibr) .
High-Fat Meal
EXPERIMENTALThe 3 Groups (Control, T1DM, T2DM) will receive 4 meals with different compositions at 4 occasions (High-Carb, High-Fat, High-Protein, High-Fibr) .
High-Fibre Meal
EXPERIMENTALThe 3 Groups (Control, T1DM, T2DM) will receive 4 meals with different compositions at 4 occasions (High-Carb, High-Fat, High-Protein, High-Fibr).
Interventions
At 4 different occasions the participants will receive meals with the same amount of calories and different composition of fat, protein, carbohydrate and fiber.The composition of the meals is: Low-fat / high-carbohydrate meal (18 E% proteins, 28 E% fat and 54% carbohydrates), high-fat meal (18 E% protein, 50 E% fat and 31 E% carbohydrate), high-protein meal (40 E% protein, 30 E% fat and 30 E% carbohydrates) and low-fat / high-carbohydrate and high fiber (18 E% proteins, 28 E% fat and 54 E% carbohydrates and 15 gram of fibers).
Eligibility Criteria
You may qualify if:
- Patient with type 1 DM (age 20-75 years)
- Patient with type 2 DM (diabetes duration more than 5 years, age 20- 75 years, BMI 26 - 33 kg/m2).
- Healthy volunteers (age 20- 75 years).
You may not qualify if:
- Heart failure - the New York Heart Association (NYHA) Functional Classification III-IV
- Kidney failure - S-Creatinin mora than 200 micromol/L
- Liver disease - Alanine aminotransferase (ALAT) more than 2 mikroKat/L
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karolinska University Hospital
Stockholm, 17176, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neda R Ekberg, M.D./Ph.D.
Karolinska University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D/Ph.D
Study Record Dates
First Submitted
August 26, 2015
First Posted
September 9, 2015
Study Start
November 1, 2009
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
March 6, 2019
Record last verified: 2019-03